(2020d)
Cardioprotection resulting from glucagon-like peptide-1 administration involves shifting metabolic substrate utilization to increase energy efficiency in the rat heart
This increase in bioavailability of N-3 PUFAs could lead to a more anti-inflammatory environment [189] in these brain regions, potentially modulating microglia
It is generally used for conditions such as melasma, sun damage, and postinflammatory hyperpigmentation
Butler J, Abildstrm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Nez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN
Storage & Handling Keep the vial sealed until required for laboratory work Protect from light, moisture and contamination Minimise unnecessary temperature variation Follow the storage conditions stated on the label and batch documentation Do not infer preparation or stability conditions from generic peptide guidance Laboratory Research Use Only Not supplied as a medicine or dietary supplement Not intended for human or veterinary use Not supplied for diagnostic or therapeutic application Why Choose D&L Peptides
